Ace:
News
News
The webinar “Molecular Biomarkers of Neurodegeneration” stands out for the high participation of attendees
01/06/2021
More than 165 attendees of 18 different nationalities gathered to hear the latest news on molecular biomarkers in neurodegenerative diseases
An Ace study demonstrates the efficacy of teleneuropsychology in diagnosis
06/07/2021Diagnosis
The variables studied were the structure of the test, the degree of interpretation of the data and its ability to detect cognitive impairment.
The first edition of the Global Research Summit closes with successful attendance
01/07/2021Research
More than 300 professionals in the field of dementia from 18 nationalities have participated in the three sessions of the Ace Global Research Summit 2021.
The United States approves the use of Aducanumab: a treatment for Alzheimer's disease
11/06/2021Day care and treatment
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.
Fundació Mir-Puig, collaborator of Ace Alzheimer Center Barcelona
10/06/2021SCR
The charity based in Barcelona signs a collaboration agreement to offer financial support to the research projects that Ace develops.
The webinar “Molecular Biomarkers of Neurodegeneration” stands out for the high participation of attendees
01/06/2021News
More than 165 attendees of 18 different nationalities gathered to hear the latest news on molecular biomarkers in neurodegenerative diseases